Record

Ref NoRCP/COL/9/929
TitleConsultation response to the National Institute for Health and Clinical Excellence on 'Single Technology Appraisal (STA) Natalizumab for the treatment of multiple sclerosis'
Date2006
Extent1 file
Add to My Items